EP0546075A1 - Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic - Google Patents

Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic

Info

Publication number
EP0546075A1
EP0546075A1 EP91916515A EP91916515A EP0546075A1 EP 0546075 A1 EP0546075 A1 EP 0546075A1 EP 91916515 A EP91916515 A EP 91916515A EP 91916515 A EP91916515 A EP 91916515A EP 0546075 A1 EP0546075 A1 EP 0546075A1
Authority
EP
European Patent Office
Prior art keywords
yeast
side effects
active
garlic
onion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP91916515A
Other languages
German (de)
French (fr)
Other versions
EP0546075A4 (en
Inventor
Sterling Chaykin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0546075A1 publication Critical patent/EP0546075A1/en
Publication of EP0546075A4 publication Critical patent/EP0546075A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14Yeasts or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • the present invention relates to a method of reducing undesirable side effects of eating certain vegetables (e.g. onion and garlic) .
  • the digestion of these and other vegetables such as cabbage, cucumber, radish and beans can lead to digestive distress, including burping and flatulence.
  • the malodorous breath and perspiration tend to be caused by sulfur- containing compounds, such as dimethylsulfide, methymercaptan, and hydrogen ⁇ ulfide.
  • Intestinal distress results from a buildup of these and other gases (including carbon dioxide and methane) in the intestine. The escape of intestinal gases produces buzping and flatulence.
  • U.S. Patent 4,634,588 discloses that the residue produced by the removal of water and alcohol from wine or from the alcohol extract of fermentation residue will alleviate the side effects of malodors including that of garlic.
  • the extraction procedures are so harsh that if active enzymes or live yeast were present, their activity would have been severely diminished or destroyed. Moreover, if live yeast or yeast enzymes were present, they would be unprotected from the acidity and proteolytic activity of the stomach and anterior intestine.
  • a grape juice has been sold which ferments at a pH of about 3.2 to 3.6 to produce some wine yeast growth. However, such product, if unprotected, would pass through the stomach to the mid and posterior intestine in an inactive form.
  • yeast has been sold as a dietary supplement.
  • brewer's yeast has been sold for that purpose in health food stores.
  • it is processed under adverse conditions (e.g. alkaline washing, solvent extractions, and drying conditions) which render it unprotected from the acidity and proteolytic activity of the stomach and anterior intestine, causing inactivity.
  • adverse conditions e.g. alkaline washing, solvent extractions, and drying conditions
  • active yeast may be employed to reduce or eliminate the foregoing undesirable side effects. Specifically, when a person eating the vegetables ingests dry active yeast in a form which retains substantial enzymatic activity under conditions present in the stomach and intestinal tract, in sufficient quantities, it will significantly reduce or eliminate the undesirable side effects normally resulting from eating the vegetables.
  • the active yeast is in dry form and protected by an enteric coating.
  • dry active yeast refers to a viable dry active yeast containing the desired enzymes or a yeast product which is not viable but which contains yeast enzymes in active form.
  • the activity is measured by the ability of the yeast enzymes to significantly reduce or eliminate the side effects of eating certain vegetables. Specifically, such activity is sufficient to significantly reduce or eliminate the malodorous effects on breath, perspiration and saliva from eating garlic or onion.
  • • ⁇ activity means the ability to provide the foregoing benefits to an adult of average weight who ingests 30 grams of green onion and 15 grams of garlic by using 0.5 grams of the yeast in dry form. The activity is also sufficient to significantly reduce or eliminate the digestive tract discomfort side effect (including gas pain, burping and flatulence) caused by ingesting garlic, onion, cabbage, cucumber, radish or beans.
  • onion means the onion family including green onions, fresh or dried onions, leaks and chives.
  • “cabbage” means the cabbage family including cabbage, brussel sprouts, cauliflower and broccoli.
  • the activity of the yeast is expressed after the yeast has passed the acidity and proteolytic conditions of the stomach and anterior intestine. This is because the yeast enzymes are believed to perform during normal digestion by redirecting the digestive fates of the parent compounds from which the malodors and other undesirable digestive gases come, converting these parent compounds, which originate in the vegetables cited above, to compounds other than malodors and other undesirable digestive gases.
  • the active dry yeast typically has a moisture content in the range 7.5-8.3% water and should not have been exposed to a temperature in excess of about 45*C.
  • brewer's yeast sold in health food stores as a diet supplement typically is processed under substantially more adverse conditions. It has been determined that such yeast, without a protective coating, would be inadequately protected to survive the conditions of the stomach and anterior intestine.
  • the yeast Although not essential, it is preferable for the yeast to have been grown under conditions which will survive the low pH of the stomach and anterior intestine. In that regard, the preferred yeast would be grown at a pH of no greater than about 3.2. Otherwise, it may be necessary to provide an enteric coating.
  • yeast The most effective type of yeast, generically called a wine yeast, is sold under the strain designations "Montrachet” and “Pasteur Champagne” yeast, suitably supplied by Universal Foods under the designation "Active Dry”. So long as this yeast is not subjected to temperatures substantially in excess of room temperature, and/or in the presence of oxygen and/or excess humidity for long periods, it has been found to survive the conditions of the stomach and anterior intestine so as to be effective even without an enteric coating.
  • Active dry baker's yeast is another suitable form of yeast. Preferably it should be coated by an enteric coating for protection from the harsh conditions of the stomach and anterior intestine. Suitable baker's yeast is sold under the designation Active Dry by Universal Foods and Fleisman.
  • Brewer's yeast is also an effective form of active dry yeast. It, too, can be effective without an enteric coating.
  • the preferred form of the active dry yeast product of the present invention is one which is enterically coated. This allows for a wide variety of yeast strains which will remain active on passage through the stomach and anterior intestine. Any of the known enteric coatings may be used in accordance with the present invention. Specifically, such coatings should be capable of protecting the yeast during passage through the stomach and anterior intestine and releasing the yeast on passage through the mid and posterior intestine. Suitable enteric coatings are disclosed in International Encyclopedia of Pharmacology and Therapeutics, ⁇ 39B, "Pharmacology of Intestinal Absorption of Drugs", Vol. 1, . Forth and . Rummel (Editors), Pergamon Press, New York, 1975, p.385-6. Suitable coatings include vegetable oil, mineral oil, waxes, esters, polymers, pH dependent coatings and pharmaceutical shellacs.
  • the active dry yeast may also be employed, particularly of the wine yeast type.
  • the product could be sprinkled in a powder onto the food, or compacted into the form of a pill, packed into a gelatin capsule, or formed into a caplet, tablet or lozenge.
  • the yeast can be formulated into candy or other edible material, so long as it is in a form which survives the conditions of the stomach and anterior intestine.
  • the dosage of the yeast depends upon the quantity of vegetable consumed with the corresponding malodor and digestive distress potential of the meal, together with the digestive characteristics of the subject.
  • wine yeast active dry Pasteur Champagne yeast
  • at a dosage of at least about 0.5 grams will protect against the malodorous and digestive tract distress potential of 30 grams of green onions and 15 grams of garlic, both consumed in the same meal.
  • the same yeast at a dosage of 1.0 grams will protect against the digestive distress potential of 150 grams of baked beans, 200 grams of cucumbers, 200 grams of cabbage, all consumed at the same meal.
  • a suitable dosage range of active dry yeast is at least about 0.25 grams, on the order of 0.25 to 5.0 grams per meal and, preferably, 0.5 to 1.0 grams.
  • the timing of consumption of the dry active yeast product of the present invention is preferably during the course of the meal or slightly before, say within one hour. Moreover, it could be taken a short time after completing the meal, e.g. within 15 minutes.

Abstract

Procédé de diminution ou d'élimination des effets secondaires indésirables dus à l'ingestion de légumes tels que l'ail, l'oignon, le chou, le concombre, le radis ou les haricots. Les effets secondaires comprennent des réactions malodorantes par l'haleine, la transpiration et la salive, des ballonnements douloureux, des renvois et des flatulences. Le procédé comprend l'ingestion d'une levure sèche active sous une forme qui maintient sensiblement l'activité enzymatique dans les conditions présentes dans l'appareil gastrique et intestinal. L'invention décrit également une levure sèche active et pourvue d'un revêtement, utilisée avec le procédé.Method for reducing or eliminating undesirable side effects caused by the ingestion of vegetables such as garlic, onion, cabbage, cucumber, radish or beans. Side effects include smelly breath, sweating and saliva, painful bloating, discharge, and flatulence. The method includes ingestion of an active dry yeast in a form which substantially maintains the enzyme activity under the conditions present in the gastric and intestinal tract. The invention also describes an active dry yeast provided with a coating, used with the process.

Description

METHOD AND PRODUCT FOR ELIMINATING UNDESIRABLE SIDE EFFECTS OF EATING VEGETABLES SUCH AS ONION OR GARLIC
Background of the Invention
The present invention relates to a method of reducing undesirable side effects of eating certain vegetables (e.g. onion and garlic) .
A person eating certain vegetables, such as onion and garlic, typically exhibits malodorous breath and perspiration within a few hours. The digestion of these and other vegetables such as cabbage, cucumber, radish and beans can lead to digestive distress, including burping and flatulence. The malodorous breath and perspiration tend to be caused by sulfur- containing compounds, such as dimethylsulfide, methymercaptan, and hydrogen εulfide. Intestinal distress results from a buildup of these and other gases (including carbon dioxide and methane) in the intestine. The escape of intestinal gases produces buzping and flatulence. The passage of such sulfur- containing compounds across the intestinal vail and into the blood stream causes them to be exhaled through the lungs and secreted as sweat, saliva and other bodily fluids. A variety of techniques have been used for alleviating certain of the undesirable side effects. In general, these techniques are cosmetic and involve masking malodors and other aromas, or removing them from the mouth through chemistry, for example, chlorophyll- containing products. Further, intestinal gas buildup is minimized by facilitating the elimination of microbubbles. These approaches do no change the underlying digestive processes.
U.S. Patent 4,634,588 discloses that the residue produced by the removal of water and alcohol from wine or from the alcohol extract of fermentation residue will alleviate the side effects of malodors including that of garlic. The extraction procedures are so harsh that if active enzymes or live yeast were present, their activity would have been severely diminished or destroyed. Moreover, if live yeast or yeast enzymes were present, they would be unprotected from the acidity and proteolytic activity of the stomach and anterior intestine.
A grape juice has been sold which ferments at a pH of about 3.2 to 3.6 to produce some wine yeast growth. However, such product, if unprotected, would pass through the stomach to the mid and posterior intestine in an inactive form.
Also, various forms of yeast have been sold as a dietary supplement. For example, brewer's yeast has been sold for that purpose in health food stores. However, it is processed under adverse conditions (e.g. alkaline washing, solvent extractions, and drying conditions) which render it unprotected from the acidity and proteolytic activity of the stomach and anterior intestine, causing inactivity. (Gerald Reed and HenryJ. Peppier, Yeast Technology. Westport, Conn, Avi Publishing co. , Inc., 1973; in particular, Chapters 5 and 11 and references contained therein) .
Summary of the Invention
In accordance with the present invention, it is found that active yeast may be employed to reduce or eliminate the foregoing undesirable side effects. Specifically, when a person eating the vegetables ingests dry active yeast in a form which retains substantial enzymatic activity under conditions present in the stomach and intestinal tract, in sufficient quantities, it will significantly reduce or eliminate the undesirable side effects normally resulting from eating the vegetables. In a preferred embodiment, the active yeast is in dry form and protected by an enteric coating.
Detailed Description of Preferred Embodiments
As used herein, the term " dry active yeast" refers to a viable dry active yeast containing the desired enzymes or a yeast product which is not viable but which contains yeast enzymes in active form. The activity is measured by the ability of the yeast enzymes to significantly reduce or eliminate the side effects of eating certain vegetables. Specifically, such activity is sufficient to significantly reduce or eliminate the malodorous effects on breath, perspiration and saliva from eating garlic or onion.
As used herein, •activity" means the ability to provide the foregoing benefits to an adult of average weight who ingests 30 grams of green onion and 15 grams of garlic by using 0.5 grams of the yeast in dry form. The activity is also sufficient to significantly reduce or eliminate the digestive tract discomfort side effect (including gas pain, burping and flatulence) caused by ingesting garlic, onion, cabbage, cucumber, radish or beans.
As used herein, "onion" means the onion family including green onions, fresh or dried onions, leaks and chives.
As used herein, "cabbage" means the cabbage family including cabbage, brussel sprouts, cauliflower and broccoli.
The activity of the yeast is expressed after the yeast has passed the acidity and proteolytic conditions of the stomach and anterior intestine. This is because the yeast enzymes are believed to perform during normal digestion by redirecting the digestive fates of the parent compounds from which the malodors and other undesirable digestive gases come, converting these parent compounds, which originate in the vegetables cited above, to compounds other than malodors and other undesirable digestive gases.
There are a number of factors which are important in determining the activity of the dry yeast. They include the yeast growing conditions, the yeast harvesting and drying conditions, the appropriate strain of yeast, and the presence of an enteric coating. The conditions of drying and extraction must be such as not to inactivate the yeast or enzymes contained therein. In that regard, the active dry yeast typically has a moisture content in the range 7.5-8.3% water and should not have been exposed to a temperature in excess of about 45*C. In contrast, brewer's yeast sold in health food stores as a diet supplement typically is processed under substantially more adverse conditions. It has been determined that such yeast, without a protective coating, would be inadequately protected to survive the conditions of the stomach and anterior intestine.
Although not essential, it is preferable for the yeast to have been grown under conditions which will survive the low pH of the stomach and anterior intestine. In that regard, the preferred yeast would be grown at a pH of no greater than about 3.2. Otherwise, it may be necessary to provide an enteric coating.
The most effective type of yeast, generically called a wine yeast, is sold under the strain designations "Montrachet" and "Pasteur Champagne" yeast, suitably supplied by Universal Foods under the designation "Active Dry". So long as this yeast is not subjected to temperatures substantially in excess of room temperature, and/or in the presence of oxygen and/or excess humidity for long periods, it has been found to survive the conditions of the stomach and anterior intestine so as to be effective even without an enteric coating.
Active dry baker's yeast is another suitable form of yeast. Preferably it should be coated by an enteric coating for protection from the harsh conditions of the stomach and anterior intestine. Suitable baker's yeast is sold under the designation Active Dry by Universal Foods and Fleisman.
Brewer's yeast is also an effective form of active dry yeast. It, too, can be effective without an enteric coating.
The preferred form of the active dry yeast product of the present invention is one which is enterically coated. This allows for a wide variety of yeast strains which will remain active on passage through the stomach and anterior intestine. Any of the known enteric coatings may be used in accordance with the present invention. Specifically, such coatings should be capable of protecting the yeast during passage through the stomach and anterior intestine and releasing the yeast on passage through the mid and posterior intestine. Suitable enteric coatings are disclosed in International Encyclopedia of Pharmacology and Therapeutics, §39B, "Pharmacology of Intestinal Absorption of Drugs", Vol. 1, . Forth and . Rummel (Editors), Pergamon Press, New York, 1975, p.385-6. Suitable coatings include vegetable oil, mineral oil, waxes, esters, polymers, pH dependent coatings and pharmaceutical shellacs.
Other forms of the active dry yeast may also be employed, particularly of the wine yeast type. Thus, the product could be sprinkled in a powder onto the food, or compacted into the form of a pill, packed into a gelatin capsule, or formed into a caplet, tablet or lozenge. In addition, the yeast can be formulated into candy or other edible material, so long as it is in a form which survives the conditions of the stomach and anterior intestine.
The dosage of the yeast depends upon the quantity of vegetable consumed with the corresponding malodor and digestive distress potential of the meal, together with the digestive characteristics of the subject. For example, wine yeast (active dry Pasteur Champagne yeast) at a dosage of at least about 0.5 grams will protect against the malodorous and digestive tract distress potential of 30 grams of green onions and 15 grams of garlic, both consumed in the same meal. Similarly, the same yeast at a dosage of 1.0 grams will protect against the digestive distress potential of 150 grams of baked beans, 200 grams of cucumbers, 200 grams of cabbage, all consumed at the same meal. A suitable dosage range of active dry yeast is at least about 0.25 grams, on the order of 0.25 to 5.0 grams per meal and, preferably, 0.5 to 1.0 grams. The timing of consumption of the dry active yeast product of the present invention is preferably during the course of the meal or slightly before, say within one hour. Moreover, it could be taken a short time after completing the meal, e.g. within 15 minutes.

Claims

WHAT IS CLAIMED IS:
1. A method for reducing or eliminating undesirable side effects of eating a vegetable selected from the group consisting of garlic, onion, cabbage, cucumber, radish and beans, said side effects including malodorous effects on breath, perspiration and saliva ordigestive tract discomfort side effects, including gas pain, burping and flatulence, said method comprising the steps of eating at least one of said vegetables and ingesting active dry yeast in a form which retains substantial enzymatic activity under conditions present in the stomach and intestinal tract, said ingested active yeast being in sufficient quantity to significantly reduce or eliminate the undesirable side effects normally resulting from eating said vegetables.
2. The method of Claim 1 in which, during ingestion, said active yeast is in dry form and protected by an enteric coating capable of protecting the yeast on passage through the stoma h and anterior portion of the intestine and of releasing said active yeast on passage through the remaining portions of the intestine.
3. The method of claim 1 in which said enteric coating is selected from the group consisting of vegetable oil, mineral oil, waxes, esters, polymers, pH dependent coatings, and pharmaceutical shellacs.
4. The method of Claim 1 in which said active dry yeast is grown at a pH lower than 3.2.
5. The method of Claim 1 in which said active dry yeast selected from the group consisting of baker's yeast, brewer's yeast and wine yeast.
6. The method of Claim 1 in which said active dry yeast has not been subjected to treatments which would destroy its viability or enzyme activity.
7. The method of Claim 1 in which said active dry yeast is contained in a vehicle selected from the group consisting of a pill, gelatin capsule, caplet, tablet, lozenge, candy or gum.
8. The method of Claim 1 in which said active dry yeast is ingested at a dosage of at least about 0.5 gm/meal.
9. The method of Claim 1 in which said vegetable is garlic or onion and said side effect comprises at least one of said malodorous effects.
10. An enterically coated active dry yeast suitable for reducing or eliminating undesirable side effects of eating a vegetable selected from the group consisting of garlic, onion, cabbage, cucumber, radish and beans, said side effects including the malodorous effects on breath, perspiration and saliva or digestive tract discomfort side effects, including gas pain, burping and flatulence, said active yeast being in a dry form which retains substantial enzymatic activity under conditions present in the stomach and intestinal tract, said enteric coating being capable of protecting the yeast from deactivation on passage through the stomach and anterior position of the intestine and of releasing said yeast on passage through the remaining portions of the intestine.
EP19910916515 1990-08-29 1991-08-29 Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic Withdrawn EP0546075A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57465390A 1990-08-29 1990-08-29
US574653 1990-08-29

Publications (2)

Publication Number Publication Date
EP0546075A1 true EP0546075A1 (en) 1993-06-16
EP0546075A4 EP0546075A4 (en) 1993-07-28

Family

ID=24297035

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910916515 Withdrawn EP0546075A4 (en) 1990-08-29 1991-08-29 Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic

Country Status (5)

Country Link
EP (1) EP0546075A4 (en)
JP (1) JP3266249B2 (en)
KR (1) KR930702013A (en)
AU (1) AU8502991A (en)
WO (1) WO1992004037A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174554B1 (en) 1996-12-20 2001-01-16 Nestic S.A. Encapsulated liquid product
US5866116A (en) * 1997-01-24 1999-02-02 Yaegaki; Ken Method for reducing oral malodor
ES2160092B2 (en) * 2000-03-17 2003-05-16 Espinos Jose Miro A PRODUCT FOR THE FERMENTATION OF BAKERY AND BAKERY MASSES AND ITS USE.
ES2172477B1 (en) * 2000-03-17 2005-04-01 Jose Miro Espinos IMPROVEMENTS IN THE PATENT OF INVENTION 200000647 FOR A PRODUCT FOR THE FERMENTATION OF BAKERY AND BAKERY MASSES AND ITS USE.
US20030198682A1 (en) * 2002-02-12 2003-10-23 Gruber James V. Composition and method for protecting labile active components during high temperature drying
EP1613738B1 (en) * 2003-04-10 2012-04-11 Lesaffre et Compagnie Yeast packaging
CN102960672B (en) * 2012-11-05 2014-04-09 北京世农国际贸易有限公司 Preparation method of organic healthy condiment of onion

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2179528A1 (en) * 1972-04-11 1973-11-23 Serozym Laboratoires Modification of micro-organisms - by addition of neodymium or magnesium chlorides or onion juice
EP0165544A1 (en) * 1984-06-11 1985-12-27 Meiji Seika Kaisha Ltd. Method for production of garlic paste

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1729752A (en) * 1926-02-23 1929-10-01 George T Southgate Deodorant composition
FR2096887A1 (en) * 1970-07-10 1972-03-03 Griffon Henri Compsn contg dried yeast with high living cell count - - for dietetic use and treating intestinal disorders
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
SE441009B (en) * 1982-03-08 1985-09-02 Kjell Nilsson WAY TO IMMOBILIZE LIVING BIOMATERIAL IN PEARLY POLYMERS
SE465951B (en) * 1984-10-23 1991-11-25 Perstorp Ab ISOMER OF INOSITOL TRIPHOSPHATE PHARMACEUTICAL STATEMENTS FOR SALT FOR USE AS THERAPEUTIC OR PROPHYLACTIC AGENTS AND COMPOSITIONS THEREOF
US4719114A (en) * 1985-01-04 1988-01-12 Durkee Industrial Foods, Corp. Encapsulated yeast
DE3738599A1 (en) * 1987-11-13 1989-05-24 Raps & Co Gewuerzwerk Encapsulated dried yeast in particle form, process for the production thereof and use thereof
US4960591A (en) * 1989-04-17 1990-10-02 Gribou Henry G Methods and compositions for relief of stomach distress

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2179528A1 (en) * 1972-04-11 1973-11-23 Serozym Laboratoires Modification of micro-organisms - by addition of neodymium or magnesium chlorides or onion juice
EP0165544A1 (en) * 1984-06-11 1985-12-27 Meiji Seika Kaisha Ltd. Method for production of garlic paste

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BUNDESVERBAND DER PHARMAZEUTISCHEN INDUSTRIE E. V. 'ROTE LISTE' 1987 , EDITIO CANTOR , AULENDORF / WÜRTT. *
See also references of WO9204037A1 *

Also Published As

Publication number Publication date
EP0546075A4 (en) 1993-07-28
JP3266249B2 (en) 2002-03-18
KR930702013A (en) 1993-09-08
WO1992004037A1 (en) 1992-03-19
JPH06500553A (en) 1994-01-20
AU8502991A (en) 1992-03-30

Similar Documents

Publication Publication Date Title
CA2243708C (en) Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection
JP3040992B2 (en) Food composition
JP4767686B2 (en) Medicine for liver protection
TW200938214A (en) Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same
EP0546075A1 (en) Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic
JPH08275752A (en) Mental/physical stress-remedying food
US6007809A (en) Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic
KR20090021584A (en) Tablet comprising vitamin c and manufacturing method thereof
JP4053686B2 (en) Bioactive health food
JP2000302694A (en) Substance usable as medicine and food
KR20220128971A (en) Composition comprising sprout wheat-derived for improvement of hepatopathy
JPWO2004077963A1 (en) Processed plant and method for producing the same
JP3178822B2 (en) 3α-hydroxysteroid dehydrogenase inhibitory activator and hyaluronidase inhibitory activator
JP2996313B2 (en) Functional health food
KR100679750B1 (en) Supplementary food composition for reducing body odor
KR100685380B1 (en) Manufacturing method of chung-guk-jang including bifidus and processed food of chung-guk-jang including bifidus
JP3497655B2 (en) Foods for preventing and eliminating bad breath, and agents for preventing and removing bad breath
JP2006348049A (en) Medicine and health food composition for promoting bloodstream by vasolidation
JP3660435B2 (en) Garlic food with reduced garlic odor and method for producing the same
JP2002053475A (en) Glucosidase inhibitor and food or beverage including the same
JP5881017B2 (en) Plant lactic acid bacteria isolated from rice husk or brown rice and use thereof
EP0068566A1 (en) Edible pharmaceutical form of a composition of matter containing a fluid dimethyl polysiloxane
RU2135034C1 (en) Method of production of nutrient mixture for organism adaptation at stress state
Imran et al. Storage quality of clove (Syzygium aromaticum) oil
RU2146481C1 (en) Method of preparing nutritive composition for adaptation of body against stress situation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930324

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19930610

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19950309

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19970301